Ana M. Gun
B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Penile human papilloma virus (HPV) in high risk populations with and without HIV: Epidemiological insights from Argentina.
Journal: International journal of STD & AIDS
Published: March 24, 2026
GITR triggering has limited impact on HIV-specific CD8 T-cell function but enhances HIV transcription reactivation from latently infected CD4 T-cells.
Journal: Scientific reports
Published: April 09, 2025
Integrative Functional Genomics Analysis of Kaposi Sarcoma Cohorts.
Journal: Research square
Published: March 31, 2025
Integrative functional genomics analysis of Kaposi sarcoma cohorts.
Journal: Scientific reports
Published: March 18, 2025
Transcriptome and microbiome-immune changes across preinvasive and invasive anal cancer lesions.
Journal: JCI insight
Published: March 12, 2024
Dual therapy based on co-formulated darunavir/ritonavir plus lamivudine for initial therapy of HIV infection: The ANDES randomized controlled trial.
Journal: International journal of antimicrobial agents
Published: January 26, 2024
Retention among transgender women treated with dolutegravir associated with tenofovir/lamivudine or emtricitabine in Argentina: TransViiV study.
Journal: PloS one
Published: June 01, 2022
Acceptability of dual HIV/syphilis rapid test in community- and home-based testing strategy among transgender women in Buenos Aires, Argentina.
Journal: International journal of STD & AIDS
Published: February 03, 2021
Longitudinal characterization of HIV-1 pol-gene in treatment-naïve men-who-have-sex-with-men from acute to chronic infection stages.
Journal: Heliyon
Published: September 22, 2020
The effect of protease inhibitor-based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART-naïve patients with HIV-infection.
Journal: HIV medicine
Published: August 11, 2020
Home-based HIV testing: Using different strategies among transgender women in Argentina.
Journal: PloS one
Published: October 27, 2019
Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial.
Journal: PloS one
Published: May 21, 2019
Last Updated: 09/26/2026